---
figid: PMC4083453__fendo-05-00099-g005
figtitle: The possible mechanisms of CRI enhancing insulin action and insulin signaling
  were shown in figure
organisms:
- NA
pmcid: PMC4083453
filename: fendo-05-00099-g005.jpg
figlink: /pmc/articles/PMC4083453/figure/F5/
number: F5
caption: The possible mechanisms of CRI enhancing insulin action and insulin signaling
  were shown in figure. The CRI treatment may directly suppress IDE and ubiquitin-proteasome
  system (UPS) in the liver, and result in reduction of insulin clearance and degradation
  of proteins (such as IRS-1 and IRS-2) in the downstream of insulin signaling pathway.
  The consequent of CRI treatment enhances insulin signaling, increases insulin sensitivity,
  and improves glucose metabolism in insulin-resistant and diabetic conditions.
papertitle: Chromiumâ€“Insulin Reduces Insulin Clearance and Enhances Insulin Signaling
  by Suppressing Hepatic Insulin-Degrading Enzyme and Proteasome Protein Expression
  in KKAy Mice.
reftext: Zhong Q. Wang, et al. Front Endocrinol (Lausanne). 2014;5:99.
year: '2014'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9227459
figid_alias: PMC4083453__F5
figtype: Figure
organisms_ner:
- Homo sapiens
- Danio rerio
redirect_from: /figures/PMC4083453__F5
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4083453__fendo-05-00099-g005.html
  '@type': Dataset
  description: The possible mechanisms of CRI enhancing insulin action and insulin
    signaling were shown in figure. The CRI treatment may directly suppress IDE and
    ubiquitin-proteasome system (UPS) in the liver, and result in reduction of insulin
    clearance and degradation of proteins (such as IRS-1 and IRS-2) in the downstream
    of insulin signaling pathway. The consequent of CRI treatment enhances insulin
    signaling, increases insulin sensitivity, and improves glucose metabolism in insulin-resistant
    and diabetic conditions.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IDE
  - USP1
  - USP2
  - USP3
  - USP4
  - USP5
  - USP6
  - USP7
  - USP8
  - USP10
  - USP11
  - USP12
  - USP13
  - USP14
  - USP15
  - USP16
  - USP18
  - USP19
  - USP20
  - USP21
  - USP22
  - USP24
  - USP25
  - USP26
  - USP27X
  - USP28
  - USP29
  - USP30
  - USP31
  - USP32
  - USP33
  - USP34
  - USP35
  - USP36
  - USP37
  - USP38
  - USP39
  - USP40
  - USP41P
  - USP42
  - USP43
  - USP44
  - USP45
  - USP46
  - USP47
  - USP48
  - USP49
  - USP50
  - USP51
  - PAN2
  - USP53
  - USP54
  - USP9X
  - USP9Y
  - USPL1
  - CYLD
  - USP17L1
  - USP17L2
  - IRS1
  - IRS2
  - ide
  - irs1
  - irs2b
  - glucose
---
